- Supported exchanges /
- AU /
- RGT.AU
Argent Biopharma Limited (RGT AU) stock market data APIs
Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Argent Biopharma Limited Financial Data Overview
| 0.32 | |
| 0.32 | |
| - | |
| 0.32 | |
| 0.32 | |
| 0.15-3 | |
| 15 490 K | |
| 48 406 K | |
| 891 K | |
| 1.052 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Argent Biopharma Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 891 K
- EBITDA -17 502 206
- Earnings Per Share -0.47
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Argent Biopharma Limited Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Argent Biopharma Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
